Reconstituted Board to Revitalize COSCIENS TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) today announced that it has entered into a resolution agreement (the “Resolution Agreement”) with Goodwood Inc., Goodwood Fund and Puccetti Funds Management Inc. (collectively, “Goodwood”) to resolve matters relating to the upcoming annual and special meeting of COSCIENS’ shareholders that had been scheduled to be held on June 26, 2025 (the “2025 Annual Meeting”). Pursuant t ...

New York, May 30, 2025 (GLOBE NEWSWIRE) -- Oak Woods Acquisition Corporation. (Nasdaq: OAKU) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on May 27, 2025, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Quarterly Report”). The Nasdaq Listing Rule requires listed companies to timely file all required ...

BATAVIA, Ill., May 30, 2025 (GLOBE NEWSWIRE) -- High Wire Networks, Inc. (OTCQB: HWNI), a global provider of managed cybersecurity services, today announced that its board of directors has determined to effect a one-for-250 reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Mark Porter, High Wire Networks CEO commented, “This is an important and essential step in our ongoing efforts to become listed on a major exchange. Inclusive of increasing our stock pric ...

Core Viewpoint - Banqup Group SA has received approval from the Swedish Competition Authority for the sale of all shares in the 21 Grams Group to PostNord Strålfors AB, marking a significant step towards completing the transaction [1] Group 1: Transaction Details - The transaction is expected to close in the first half of 2025 [2] - The approval decision has been published on the Swedish Competition Authority's website [1] Group 2: Company Overview - Banqup Group provides integrated cloud-based SaaS solutions that streamline business transactions, including e-invoicing, e-payments, and tax reporting [3] - The company's solution, Banqup, integrates various financial processes into a single secure platform, simplifying operations for businesses [3] - eFaktura World is designed for governments to implement e-invoicing and streamline tax reporting flows [3] Group 3: Financial Calendar - H1 2025 results will be published on 26 August 2025 [5] - Q3 2025 business update is scheduled for 13 November 2025 [5]

Core Viewpoint - ContextLogic Inc. intends to voluntarily delist from The Nasdaq Global Market and begin trading on the OTCQB® Venture Market starting June 3, 2025 [1][2][3] Group 1: Delisting and Listing Details - The Company has been accepted for listing on the OTCQB® Venture Market, with its Class A Common Stock commencing trading under the ticker symbol "LOGC" on June 3, 2025 [2] - The Company plans to file a Form 25 with the U.S. Securities and Exchange Commission (SEC) around June 9, 2025, to initiate the delisting process from Nasdaq [3] - The delisting from Nasdaq is expected to become effective 10 days after the filing, unless directed otherwise by Nasdaq [3] Group 2: Background and Rationale - The Company was notified by Nasdaq's Listing Qualifications Department that it was considered a "public shell," which could lead to delisting unless a hearing was requested [4] - A hearing was held on May 8, 2025, where the Company presented its business overview and efforts to maximize asset value [5] - The Board of Directors unanimously determined that delisting from Nasdaq is in the best interests of the Company, considering regulatory requirements, compliance costs, and time management [6][7] Group 3: Future Strategy - The transition to the OTC Markets is expected to save expenses and maintain an orderly trading market for the Company's Common Stock [7] - The Company's strategy and operations will remain unchanged despite the listing transfer [7] - ContextLogic is focused on developing a new business and financing potential acquisitions that complement its operations [8]

Core Viewpoint - Brag House Holdings, Inc. is actively working on its Quarterly Report for the fiscal quarter ended March 31, 2025, while addressing compliance issues with Nasdaq due to delayed filings [1][2]. Company Compliance and Reporting - On May 27, 2025, Brag House received a notice from Nasdaq for non-compliance with Listing Rule 5250(c)(1) due to the delayed filing of its Form 10-Q [2]. - The company plans to file its Form 10-Q before the compliance plan submission deadline of July 28, 2025, ensuring no immediate effect on its stock listing [2]. Leadership Commitment - CEO Lavell Juan Malloy II emphasized the company's commitment to transparency and compliance with SEC reporting obligations, highlighting the team's efforts to complete necessary disclosures while focusing on strategic goals [3]. Engagement Initiatives - Brag House launched the Brag Gators Gauntlet: Baseball Edition in partnership with Florida Gators Athletics, featuring a Fortnite tournament that attracted strong participation from students and alumni [4]. - The event served as a gamified digital tailgate, enhancing engagement for college sports fans [4]. - Following the success of the inaugural event, Brag House plans to host the next activation on July 19, 2025, and aims to roll out additional events at various universities throughout 2025 [5]. Company Overview - Brag House is a media technology gaming platform focused on transforming casual college gaming into a community-driven experience, integrating gaming, social interaction, and technology [6]. - The platform aims to foster meaningful engagement between users and brands, particularly targeting the influential Gen Z demographic [6].

Core Insights - Fate Therapeutics, Inc. has appointed Matthew Abernethy to its Board of Directors, effective May 29, 2025, while Timothy P. Coughlin has stepped down from the Board [1][2] Company Overview - Fate Therapeutics is a clinical-stage biopharmaceutical company focused on developing induced pluripotent stem cell (iPSC)-derived cellular immunotherapies [4] - The company aims to create a pipeline of off-the-shelf cell therapy products targeting autoimmunity and oncology [4] Leadership Changes - Matthew Abernethy brings over 15 years of experience in corporate finance and investor relations within the biotech and medical device sectors [1][2] - Abernethy has served as Chief Financial Officer at Neurocrine Biosciences since November 2017 and has held various finance roles at Zimmer Biomet Holdings [2][3] Strategic Focus - Abernethy emphasizes the potential of cell therapy to aid patients with cancer and immunological disorders, particularly highlighting the product FT819 for autoimmune diseases like lupus [2]

Core Points - Wintergreen Acquisition Corp. has successfully closed its initial public offering (IPO) of 5,595,000 units, generating gross proceeds of $55,950,000 at a price of $10.00 per unit [1][3] - The units began trading on the Nasdaq Capital Market under the ticker symbol "WTGUU" on May 29, 2025, with each unit consisting of one ordinary share and one right [2] - The company plans to utilize the net proceeds from the offering to acquire a business in the technology, media, and telecommunications sectors, focusing on the Asia Pacific region, including Greater China [4][8] Financial Details - A total of $56,089,875 was placed into a trust account in the United States, which includes proceeds from the IPO and a private placement of 253,875 units to the sponsor, MACRO DREAM Holdings Limited, for $2,538,750 [3] - The public unit price was effectively $10.025 after accounting for the private placement [3] Legal and Regulatory Information - The registration statement for the offering was filed with the SEC and declared effective on May 28, 2025 [5] - Legal counsel for the IPO included Concord & Sage P.C. for U.S. matters and Ogier for Cayman Islands matters [5]

Group 1 - Pelican Acquisition Corporation completed the sale of an additional 1,125,000 units at a public offering price of $10.00 per unit, resulting in gross proceeds of $11,250,000, bringing the total gross proceeds from the initial public offering to $86,250,000 with 8,625,000 units issued [1] - Each unit sold consists of one ordinary share and one right, with each right entitling the holder to receive one-tenth of one ordinary share upon the consummation of an initial business combination [2] - EarlyBirdCapital, Inc. acted as the sole book-running manager, while IB Capital LLC served as co-manager for the offering [3] Group 2 - A registration statement for these securities was declared effective by the Securities and Exchange Commission on May 22, 2025, and the offering was made only by means of a prospectus [4] - Pelican Acquisition Corporation is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, without limitations on industry or geographic region [6]

Core Insights - Banco Comercial Português, S.A. has released its Q1 2025 Report and Accounts, highlighting significant financial performance and strategic initiatives [1] Financial Performance - The bank reported a net profit of €150 million for Q1 2025, representing a 10% increase compared to the same period last year [1] - Total assets reached €80 billion, showing a growth of 5% year-over-year [1] - The bank's return on equity (ROE) improved to 12%, up from 11% in Q1 2024 [1] Strategic Initiatives - The bank has focused on digital transformation, with a 20% increase in online banking users compared to the previous quarter [1] - Investment in technology infrastructure has been prioritized, with €50 million allocated for upgrades in 2025 [1] - The bank aims to expand its market presence in emerging markets, targeting a 15% growth in customer base by the end of 2025 [1]